• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.35% Nasdaq Down 0.81%

    Novo Nordisk A/S (NVO)

    -NYSE
    46.88 Down 0.53(1.12%) Aug 24, 4:02PM EDT
    Prev Close:47.41
    Open:47.46
    Bid:46.96 x 1900
    Ask:47.04 x 1600
    1y Target Est:57.00
    Beta:0.46293
    Next Earnings Date:N/A
    Day's Range:46.82 - 47.65
    52wk Range:45.80 - 59.00
    Volume:2,695,816
    Avg Vol (3m):2,090,220
    Market Cap:118.90B
    P/E (ttm):22.12
    EPS (ttm):2.12
    Div & Yield:1.41 (3.01%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVODown 1.12%118.90B
    PFEDown 0.77%211.21B
    LLYDown 1.42%82.78B

    Key Statistics

    Forward P/E (1 yr):19.37
    P/S (ttm):7.26
    Ex-Dividend Date:18-Mar-16

    Analysts

    Annual EPS Est (Dec-16) :2.27
    Quarterly EPS Est (Sep-16) :0.58
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):1.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback